ONESOURCE SPECIALTY PHARMA
|
ONESOURCE SPECIALTY PHARMA Last 5 Year Cashflow Statement History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Profit Before Tax | ₹-22 Cr | ₹-390 Cr | ₹-799 Cr |
| Adjustment | ₹285 Cr | ₹288 Cr | ₹605 Cr |
| Changes In working Capital | ₹-303 Cr | ₹-6.66 Cr | ₹19 Cr |
| Cash Flow after changes in Working Capital | ₹-40 Cr | ₹-109 Cr | ₹-176 Cr |
| Cash Flow from Operating Activities | ₹-47 Cr | ₹-109 Cr | ₹-165 Cr |
| Cash Flow from Investing Activities | ₹-300 Cr | ₹506 Cr | ₹-66 Cr |
| Cash Flow from Financing Activities | ₹417 Cr | ₹-384 Cr | ₹118 Cr |
| Net Cash Inflow / Outflow | ₹70 Cr | ₹13 Cr | ₹-112 Cr |
| Opening Cash & Cash Equivalents | ₹22 Cr | ₹9.41 Cr | ₹121 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - |
| Effect of Foreign Exchange Fluctuations | - | - | - |
| Closing Cash & Cash Equivalent | ₹92 Cr | ₹22 Cr | ₹9.41 Cr |
Compare Cashflow Statement of peers of ONESOURCE SPECIALTY PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ONESOURCE SPECIALTY PHARMA | ₹21,257.5 Cr | 2.7% | 1.2% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹405,452.0 Cr | -0.3% | 6% | -10.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,089.0 Cr | 3.9% | 18.6% | 14.5% | Stock Analytics | |
| CIPLA | ₹121,299.0 Cr | -5.2% | NA | 2.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹120,456.0 Cr | -1% | -1.2% | 8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,965.9 Cr | -6.8% | -2.1% | -8.4% | Stock Analytics | |
ONESOURCE SPECIALTY PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ONESOURCE SPECIALTY PHARMA | 2.7% |
1.2% |
|
| SENSEX | -0.3% |
4.5% |
5.7% |
You may also like the below Video Courses